{"id":"https://openalex.org/W3084765871","doi":"https://doi.org/10.1093/rheumatology/keaa424","title":"Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials","display_name":"Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials","publication_year":2020,"publication_date":"2020-07-03","ids":{"openalex":"https://openalex.org/W3084765871","doi":"https://doi.org/10.1093/rheumatology/keaa424","mag":"3084765871","pmid":"https://pubmed.ncbi.nlm.nih.gov/32910152","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7937016"},"language":"en","primary_location":{"id":"doi:10.1093/rheumatology/keaa424","doi":"https://doi.org/10.1093/rheumatology/keaa424","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaa424","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Lara D. Veeken","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1093/rheumatology/keaa424","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040511970","display_name":"Alemnew F. Dagnew","orcid":"https://orcid.org/0000-0003-4181-058X","observed_orcids":["https://orcid.org/0000-0003-4181-058X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Alemnew F Dagnew","raw_affiliation_strings":["GSK, Rockville, MD, USA"],"raw_orcid":"https://orcid.org/0000-0003-4181-058X","affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112597579","display_name":"Debora A. Rausch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debora Rausch","raw_affiliation_strings":["GSK, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084655314","display_name":"Caroline Herv\u00e9","orcid":"https://orcid.org/0000-0002-0794-8748","observed_orcids":["https://orcid.org/0000-0002-0794-8748"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Caroline Herv\u00e9","raw_affiliation_strings":["GSK, Wavre, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Wavre, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078675697","display_name":"Toufik Zahaf","orcid":"https://orcid.org/0000-0002-2049-5210","observed_orcids":["https://orcid.org/0000-0002-2049-5210"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Toufik Zahaf","raw_affiliation_strings":["GSK, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051264386","display_name":"Myron J. Levin","orcid":"https://orcid.org/0000-0002-7468-106X","observed_orcids":["https://orcid.org/0000-0002-7468-106X"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myron J Levin","raw_affiliation_strings":["Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058719258","display_name":"Anne Schuind","orcid":"https://orcid.org/0000-0003-3544-0682","observed_orcids":["https://orcid.org/0000-0003-3544-0682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Schuind","raw_affiliation_strings":["GSK, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"for the ZOE-50/70 study group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the ZOE-50/70 study group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5040511970","https://openalex.org/A5084655314"],"corresponding_institution_ids":["https://openalex.org/I4210095529"],"apc_list":{"value":3486,"currency":"GBP","value_usd":4597},"apc_paid":{"value":3486,"currency":"GBP","value_usd":4597},"fwci":4.6583,"has_fulltext":false,"cited_by_count":72,"citation_normalized_percentile":{"value":0.96013815,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"60","issue":"3","first_page":"1226","last_page":"1233"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/herpes-zoster-prevention","display_name":"herpes zoster prevention","score":0.9440000057220459},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.8320000171661377},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.8740000128746033},{"id":"https://openalex.org/keywords/vaccine-efficacy","display_name":"vaccine efficacy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.7620000243186951},{"id":"https://openalex.org/keywords/spondyloarthritis","display_name":"spondyloarthritis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7950000166893005},{"id":"https://openalex.org/keywords/immunocompetent-adult","display_name":"immunocompetent adult","score":0.5360000133514404},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9312907457351685},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.789901077747345},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.67131108045578},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.655177891254425},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.49008452892303467},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46822211146354675},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44017618894577026},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3762052059173584},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.06082308292388916},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002446","descriptor_name":"Celiac Disease","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006562","descriptor_name":"Herpes Zoster","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006562","descriptor_name":"Herpes Zoster","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025242","descriptor_name":"Spondylarthropathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D053061","descriptor_name":"Herpes Zoster Vaccine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/rheumatology/keaa424","doi":"https://doi.org/10.1093/rheumatology/keaa424","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaa424","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Lara D. Veeken","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7937016","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7937016","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford)","raw_type":"Text"},{"id":"pmid:32910152","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32910152","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/rheumatology/keaa424","doi":"https://doi.org/10.1093/rheumatology/keaa424","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaa424","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Lara D. Veeken","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F8449784507","display_name":"GlaxoSmithKline Biologicals","ror":"https://ror.org/00n3pea85"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1996985859","https://openalex.org/W2010207831","https://openalex.org/W2013400431","https://openalex.org/W2046013120","https://openalex.org/W2077550414","https://openalex.org/W2080277130","https://openalex.org/W2145347536","https://openalex.org/W2399244551","https://openalex.org/W2417382840","https://openalex.org/W2519957152","https://openalex.org/W2767394258","https://openalex.org/W2772112182","https://openalex.org/W2803294938","https://openalex.org/W2885997044","https://openalex.org/W2895888657","https://openalex.org/W2911071768","https://openalex.org/W2912441127","https://openalex.org/W2921689837","https://openalex.org/W2922062358","https://openalex.org/W2931264657","https://openalex.org/W2937719347","https://openalex.org/W2945450292","https://openalex.org/W2945651855","https://openalex.org/W2950051541","https://openalex.org/W2950959196","https://openalex.org/W2960588225","https://openalex.org/W2965743944","https://openalex.org/W2973791783"],"related_works":["https://openalex.org/W3109929429","https://openalex.org/W2931264657","https://openalex.org/W2950051541","https://openalex.org/W4416759325","https://openalex.org/W4413110961","https://openalex.org/W4406946340","https://openalex.org/W3169380512","https://openalex.org/W3216238282","https://openalex.org/W4399368711","https://openalex.org/W3131952339"],"abstract_inverted_index":{"ABSTRACT":[0],"OBJECTIVE:":[1],"In":[2,110,233],"the":[3,13,34,63,123,156,166,208,217],"ZOE-50":[4],"(NCT01165177)":[5],"and":[6,59,82,93,160,170,181,195,222,229,245,252],"ZOE-70":[7],"(NCT01165229)":[8],"phase":[9],"3":[10],"clinical":[11],"trials,":[12],"adjuvanted":[14],"recombinant":[15],"zoster":[16,25],"vaccine":[17],"(RZV)":[18],"demonstrated":[19],"\u226590%":[20],"efficacy":[21,56,124],"in":[22,27,70,184,216],"preventing":[23],"herpes":[24],"(HZ)":[26],"all":[28,146],"age":[29,219],"groups":[30],"\u226550":[31,91],"years.":[32],"Given":[33],"increased":[35],"HZ":[36,58,135,199,244],"risk":[37],"associated":[38],"with":[39,116,207,236],"certain":[40],"underlying":[41],"autoimmune":[42],"diseases":[43,78],"or":[44,105],"their":[45],"treatment":[46],"regimes,":[47],"we":[48],"conducted":[49],"a":[50],"post":[51],"hoc":[52],"analysis":[53,113],"of":[54,65,103,114],"RZV's":[55],"against":[57,198,243],"safety":[60],"profile":[61],"[specifically,":[62],"occurrence":[64,142],"serious":[66],"adverse":[67],"events":[68],"(SAEs)]":[69],"ZOE-50/70":[71,167,234],"participants":[72,115,147,235],"who":[73,130,148],"reported":[74,173],"pre-existing":[75,177,190,237],"potential":[76],"immune-mediated":[77],"(pIMDs)":[79],"at":[80,117,121,150,174,179],"enrolment":[81,180],"were":[83,97,182,192,225],"not":[84,132],"on":[85],"immunosuppressive":[86],"therapies.":[87],"METHODS:":[88],"Adults":[89],"aged":[90],"(ZOE-50)":[92],"\u226570":[94],"(ZOE-70)":[95],"years":[96],"randomized":[98],"to":[99],"receive":[100],"two":[101],"doses":[102],"RZV":[104,159,228,239,251],"placebo":[106,163,230,253],"2":[107],"months":[108],"apart.":[109],"this":[111],"subgroup":[112],"least":[118,151,175],"one":[119,152,176],"pIMD":[120,178],"enrolment,":[122],"was":[125,143,200,240,248],"calculated":[126],"for":[127,145],"two-dose":[128],"recipients":[129,164],"did":[131],"develop":[133],"confirmed":[134],"before":[136],"30":[137],"days":[138],"post-dose":[139],"2.":[140],"SAE":[141,246],"evaluated":[144],"received":[149],"dose.":[153],"RESULTS:":[154],"Of":[155],"14":[157,161],"645":[158],"660":[162],"from":[165],"studies,":[168],"983":[169],"960,":[171],"respectively,":[172],"included":[183],"these":[185],"analyses.":[186],"The":[187],"most":[188],"frequent":[189],"conditions":[191],"psoriasis,":[193],"spondyloarthropathy":[194],"RA.":[196],"Efficacy":[197],"90.5%":[201],"(95%":[202,212],"CI:":[203,213],"73.5,":[204],"97.5%)":[205],"overall":[206],"lowest":[209],"being":[210],"84.4%":[211],"30.8,":[214],"98.3%)":[215],"70-79-year-old":[218],"group.":[220],"SAEs":[221,224],"fatal":[223],"similar":[226,249],"between":[227,250],"recipients.":[231,254],"CONCLUSION:":[232],"pIMDs,":[238],"highly":[241],"efficacious":[242],"incidence":[247],"TRIAL":[255],"REGISTRATION:":[256],"ClinicalTrials.gov,":[257],"https://clinicaltrials.gov,":[258],"NCT01165177":[259],"(ZOE-50),":[260],"NCT01165229":[261],"(ZOE-70).":[262]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":19},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-09-21T00:00:00"}